METTL3 positively regulates prostate cancer cell proliferation and metastasis through GLI1 rather than other components of the SHH cascade in an m6A modification-dependent manner, while the underlying mechanism remains to be investigated further [32]. The gene discussed is GLI1; the disease is prostate carcinoma.